Carnumax

GLS Pharma is an Indian pharmaceutical company, now a wholly-owned subsidiary of Aurobindo Pharma, specializing in the development and manufacture of oncology and critical care medications. The company is widely recognized for its product Carnumax, a brand of carmustine used as a chemotherapy agent for brain tumors, multiple myeloma, and lymphomas. GLS Pharma's portfolio includes a variety of antineoplastic agents, such as cisplatin, carboplatin, and cytarabine, as well as supportive care drugs like dexamethasone. The company operates a manufacturing facility in Hyderabad and a corporate office in New Delhi, focusing on providing high-quality, affordable generic versions of essential specialty medicines. Founded in 2004 by Suresh Pathak, GLS Pharma has established a significant presence in the oncology market through its backward integration and API manufacturing capabilities.